AP2015008604A0 - Chemical compounds - Google Patents
Chemical compoundsInfo
- Publication number
- AP2015008604A0 AP2015008604A0 AP2015008604A AP2015008604A AP2015008604A0 AP 2015008604 A0 AP2015008604 A0 AP 2015008604A0 AP 2015008604 A AP2015008604 A AP 2015008604A AP 2015008604 A AP2015008604 A AP 2015008604A AP 2015008604 A0 AP2015008604 A0 AP 2015008604A0
- Authority
- AP
- ARIPO
- Prior art keywords
- chemical compounds
- compounds
- chemical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13305078 | 2013-01-23 | ||
PCT/GB2014/050163 WO2014114928A1 (en) | 2013-01-23 | 2014-01-22 | Chemical compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
AP2015008604A0 true AP2015008604A0 (en) | 2015-07-31 |
Family
ID=47623992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2015008604A AP2015008604A0 (en) | 2013-01-23 | 2014-01-22 | Chemical compounds |
Country Status (27)
Country | Link |
---|---|
US (2) | US9156831B2 (ru) |
EP (1) | EP2948447B1 (ru) |
JP (1) | JP6307096B2 (ru) |
KR (1) | KR102202516B1 (ru) |
CN (1) | CN104936953B (ru) |
AP (1) | AP2015008604A0 (ru) |
AR (1) | AR094553A1 (ru) |
AU (1) | AU2014208964B2 (ru) |
BR (1) | BR112015017331B1 (ru) |
CA (1) | CA2897279C (ru) |
CL (1) | CL2015002027A1 (ru) |
CR (1) | CR20150367A (ru) |
DO (1) | DOP2015000170A (ru) |
ES (1) | ES2608395T3 (ru) |
HK (1) | HK1214592A1 (ru) |
IL (1) | IL239890A0 (ru) |
MA (1) | MA38287B1 (ru) |
MX (1) | MX361136B (ru) |
NI (1) | NI201500096A (ru) |
PE (1) | PE20151979A1 (ru) |
PH (1) | PH12015501584A1 (ru) |
RU (1) | RU2644769C2 (ru) |
SG (1) | SG11201505631PA (ru) |
TN (1) | TN2015000313A1 (ru) |
TW (1) | TWI606047B (ru) |
UY (1) | UY35275A (ru) |
WO (1) | WO2014114928A1 (ru) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016146591A1 (en) * | 2015-03-16 | 2016-09-22 | Astrazeneca Ab | Combination treatment |
TW201726140A (zh) | 2015-09-17 | 2017-08-01 | 瑞典商阿斯特捷利康公司 | 治療癌症之新型生物標記及方法 |
TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
CN107137405A (zh) * | 2017-04-14 | 2017-09-08 | 黄德莲 | 一种治疗肾炎的药物组合物 |
CN110317190A (zh) * | 2018-03-28 | 2019-10-11 | 首都医科大学 | 一种三唑-羧酸酯类衍生物在医药领域的应用 |
MX2021004775A (es) | 2018-11-05 | 2021-06-08 | Iovance Biotherapeutics Inc | Expansion de linfocitos infiltrantes de tumores (tils) usando inhibidores de la via de proteina cinasa b (akt). |
WO2020094363A1 (en) | 2018-11-05 | 2020-05-14 | Syngenta Participations Ag | Pesticidally active azole-amide compounds |
ES2953140T3 (es) | 2019-03-08 | 2023-11-08 | Syngenta Crop Protection Ag | Compuestos de azol-amida activos de manera plaguicida |
EP3941912B1 (en) | 2019-03-20 | 2023-12-13 | Syngenta Crop Protection AG | Pesticidally active azole amide compounds |
WO2020193341A1 (en) | 2019-03-22 | 2020-10-01 | Syngenta Crop Protection Ag | N-[1-(5-bromo-2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-2-cyclopropyl-6-(trifluoromethyl)pyridine-4-carboxamide derivatives and related compounds as insecticides |
PE20221838A1 (es) | 2020-04-24 | 2022-11-29 | Astrazeneca Ab | Formulaciones farmaceuticas |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7112373A (ru) | 1970-09-25 | 1972-03-28 | ||
US4256887A (en) | 1978-04-06 | 1981-03-17 | Merck & Co., Inc. | 1,2,4-Triazoles and a method for their preparation |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
JP3028168B2 (ja) | 1993-03-29 | 2000-04-04 | 住化ファインケム株式会社 | ベンゼンスルホンアミド誘導体の製造方法 |
US5656416A (en) | 1994-12-22 | 1997-08-12 | Eastman Kodak Company | Photographic processing composition and method using organic catalyst for peroxide bleaching agent |
ATE197300T1 (de) | 1995-02-02 | 2000-11-15 | Smithkline Beecham Plc | Indolderivate als 5-ht rezeptorantagoniste |
GB9517559D0 (en) | 1995-08-26 | 1995-10-25 | Smithkline Beecham Plc | Novel compounds |
ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
WO1998004560A1 (en) | 1996-07-25 | 1998-02-05 | Merck Sharp & Dohme Limited | SUBSTITUTED TRIAZOLO PYRIDAZINE DERIVATIVES AS INVERSE AGONISTS OF THE GABAAα5 RECEPTOR SUBTYPE |
GB9711753D0 (en) | 1997-06-06 | 1997-08-06 | Merck Sharp & Dohme | Therapeutic agents |
JP3983662B2 (ja) | 2000-07-19 | 2007-09-26 | エフ.ホフマン−ラ ロシュ アーゲー | ピリミジン誘導体 |
DK1446387T3 (da) | 2001-11-21 | 2009-12-21 | Pharmacia & Upjohn Co Llc | Substituerede aryl, 1,4-pyrazinderivater |
US7012077B2 (en) | 2001-12-20 | 2006-03-14 | Hoffmann-La Roche Inc. | Substituted cyclohexane derivatives |
EP1467986A1 (en) | 2002-01-17 | 2004-10-20 | Eli Lilly And Company | Aza-cyclic compounds as modulators of acetylcholine receptors |
US20030195192A1 (en) | 2002-04-05 | 2003-10-16 | Fortuna Haviv | Nicotinamides having antiangiogenic activity |
AU2003234464B2 (en) | 2002-05-03 | 2009-06-04 | Exelixis, Inc. | Protein kinase modulators and methods of use |
GB0306097D0 (en) | 2003-03-15 | 2003-04-23 | Elam T Ltd | Electroluminescent complexes |
JP2006520794A (ja) | 2003-03-21 | 2006-09-14 | スミスクライン ビーチャム コーポレーション | 化合物 |
DE10348044A1 (de) | 2003-10-15 | 2005-05-19 | Imtm Gmbh | Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
DK1704145T3 (da) | 2004-01-12 | 2012-09-24 | Ym Biosciences Australia Pty | Selektive kinaseinhibitorer |
AU2005252160A1 (en) | 2004-04-13 | 2005-12-22 | Astellas Pharma Inc. | Polycyclic pyrazines as potassium ion channel modulators |
JP2006028056A (ja) | 2004-07-14 | 2006-02-02 | Agro Kanesho Co Ltd | ピリミジン誘導体及びこれを含む有害生物防除剤 |
DK1786790T3 (da) | 2004-07-26 | 2009-07-20 | Lilly Co Eli | Oxazolderivater som histamin H3 receptorstoffer, fremstilling og terapeutiske anvendelser |
BRPI0515483A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos para o tratamento de doenças mediadas por enzimas estearoil-coa desaturase |
BRPI0515505A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase |
BRPI0515488A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados de heterocìclicos e seu uso como agentes terapêuticos |
US7910561B2 (en) | 2004-12-15 | 2011-03-22 | Merck Sharp & Dohme Corp. | Inhibitors of Akt activity |
US7834181B2 (en) | 2005-02-01 | 2010-11-16 | Slaon-Kettering Institute For Cancer Research | Small-molecule Hsp90 inhibitors |
US8008317B2 (en) | 2005-06-10 | 2011-08-30 | Merck Sharp & Dohme Corp. | Inhibitors of akt activtiy |
WO2007096764A2 (en) | 2006-02-27 | 2007-08-30 | Glenmark Pharmaceuticals S.A. | Bicyclic heteroaryl derivatives as cannabinoid receptor modulators |
ATE453635T1 (de) | 2006-03-22 | 2010-01-15 | Vertex Pharma | C-met-proteinkinasehemmer zur behandlung proliferativer erkrankungen |
TW200808800A (en) | 2006-05-05 | 2008-02-16 | Astrazeneca Ab | MGluR5 modulators V |
CN101472912A (zh) | 2006-06-22 | 2009-07-01 | 比奥维特罗姆上市公司 | 作为mnk激酶抑制剂的吡啶和吡嗪衍生物 |
US10336757B2 (en) | 2006-06-30 | 2019-07-02 | Sloan-Kettering Institute For Cancer Research | Treatment of neurodegenerative diseases through inhibition of HSP90 |
MX2009000771A (es) | 2006-07-21 | 2009-01-30 | Irm Llc | Compuestos y composiciones como inhibidores de itpkb. |
CA2659851C (en) | 2006-08-23 | 2014-02-25 | Kudos Pharmaceuticals Limited | 2-methylmorpholine pyrido-, pyrazo- and pyrimido-pyrimidine derivatives as mtor inhibitors |
US8119671B2 (en) | 2007-03-07 | 2012-02-21 | Nissan Chemical Industries, Ltd. | Isoxazoline-substituted benzamide compound and pest control agent |
RS52559B (en) | 2007-08-14 | 2013-04-30 | Bayer Intellectual Property Gmbh | FUSIONED BICYCLIC PYRIMIDINES |
WO2009024825A1 (en) | 2007-08-21 | 2009-02-26 | Astrazeneca Ab | 2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors |
WO2009047563A1 (en) | 2007-10-11 | 2009-04-16 | Astrazeneca Ab | Pyrrolo [2, 3 -d] pyrimidin derivatives as protein kinase b inhibitors |
AU2008315746A1 (en) | 2007-10-25 | 2009-04-30 | Astrazeneca Ab | Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders |
WO2009072621A1 (ja) | 2007-12-07 | 2009-06-11 | Nissan Chemical Industries, Ltd. | 置換ジヒドロアゾール化合物及び有害生物防除剤 |
WO2009079008A1 (en) | 2007-12-19 | 2009-06-25 | Yangbo Feng | Benzopyrans and analogs as rho kinase inhibitors |
EP2238134A2 (en) | 2007-12-20 | 2010-10-13 | Novartis AG | Bis-thiazole derivatives, process for their preparation and their use as medicaments |
WO2009157880A1 (en) | 2008-06-27 | 2009-12-30 | S*Bio Pte Ltd | Pyrazine substituted purines |
MX2011002367A (es) | 2008-09-02 | 2011-04-04 | Novartis Ag | Inhibidores de cinasa biciclicos. |
JP2010083883A (ja) | 2008-09-08 | 2010-04-15 | Nissan Chem Ind Ltd | イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤 |
UA104147C2 (ru) * | 2008-09-10 | 2014-01-10 | Новартис Аг | Производная пирролидиндикарбоновой кислоты и ее применение в лечении пролиферативных заболеваний |
JP2010063863A (ja) | 2008-09-11 | 2010-03-25 | Mugen:Kk | ヘッドのフェース部背面に音響振動の異なるパイプまたは平板を複数設けた打点位置表示型ゴルフ練習用クラブとその製法 |
CN101676271B (zh) | 2008-09-17 | 2011-12-14 | 山东轩竹医药科技有限公司 | 含有不饱和杂环胺的四环素衍生物 |
EP2370424A1 (en) | 2008-11-10 | 2011-10-05 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
KR20110082569A (ko) * | 2008-11-14 | 2011-07-19 | 바이엘 쉐링 파마 악티엔게젤샤프트 | Hif 억제제로서의 헤테로시클릭 치환된 아릴 화합물 |
EP4059932A1 (en) | 2008-12-19 | 2022-09-21 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
CN102264737A (zh) | 2008-12-23 | 2011-11-30 | 雅培制药有限公司 | 抗病毒化合物 |
WO2010086613A1 (en) | 2009-01-30 | 2010-08-05 | Betagenon Ab | Compounds useful as inhibitors as ampk |
CN102317291B (zh) | 2009-02-13 | 2015-02-11 | 拜耳知识产权有限责任公司 | 稠合嘧啶 |
ES2435804T3 (es) * | 2009-02-13 | 2013-12-23 | Bayer Intellectual Property Gmbh | Pirimidinas condensadas como inhibidores de Akt |
EP2408780A2 (en) | 2009-03-20 | 2012-01-25 | Pfizer Inc. | 3-oxa-7-azabicycloý3.3.1¨nonanes |
GB0909441D0 (en) | 2009-06-02 | 2009-07-15 | Univ Sheffield | Novel indole derivatives |
US8293753B2 (en) | 2009-07-02 | 2012-10-23 | Novartis Ag | Substituted 2-carboxamide cycloamino ureas |
EP2470021B1 (en) | 2009-08-27 | 2014-10-22 | Merck Sharp & Dohme Corp. | Novel pyrrolidine derived beta 3 adrenergic receptor agonists |
EP2491039A1 (en) | 2009-10-20 | 2012-08-29 | Cellzome Limited | Heterocyclyl pyrazolopyrimidine analogues as jak inhibitors |
US8399460B2 (en) | 2009-10-27 | 2013-03-19 | Astrazeneca Ab | Chromenone derivatives |
EP2338888A1 (en) | 2009-12-24 | 2011-06-29 | Almirall, S.A. | Imidazopyridine derivatives as JAK inhibitors |
ES2627703T3 (es) | 2010-01-22 | 2017-07-31 | Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii | Inhibidores de PI3·quinasa |
CA2789021C (en) | 2010-02-05 | 2018-02-06 | Merck Patent Gmbh | Hetaryl-[1,8]naphthyridine derivatives |
JP2011178673A (ja) | 2010-02-26 | 2011-09-15 | Nissan Chem Ind Ltd | 非農園芸害虫の防除方法 |
KR20130053404A (ko) | 2010-03-30 | 2013-05-23 | 베르선 코포레이션 | 트롬빈 억제제로서의 다중치환된 방향족 화합물 |
US9133123B2 (en) | 2010-04-23 | 2015-09-15 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
AU2011253025A1 (en) | 2010-05-12 | 2012-11-29 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
CN102311396B (zh) | 2010-07-05 | 2015-01-07 | 暨南大学 | 一种吡嗪类衍生物和其制备方法及在制药中的应用 |
TWI617560B (zh) * | 2010-09-14 | 2018-03-11 | 伊塞利克斯公司 | PI3Kδ 抑制劑以及其應用和生產方法 |
RU2552114C2 (ru) * | 2010-09-16 | 2015-06-10 | Хатчисон Медифарма Лимитед | Конденсированные гетероарилы и их применение |
WO2012068589A2 (en) | 2010-11-19 | 2012-05-24 | Constellation Pharmaceuticals | Modulators of methyl modifying enzymes, compositions and uses thereof |
CN102718745A (zh) * | 2011-03-30 | 2012-10-10 | 中国科学院上海药物研究所 | 新型胺基吡啶类化合物、其制备方法、包含此类化合物的药物组合物及其用途 |
US10533000B2 (en) | 2011-05-26 | 2020-01-14 | Sunovion Pharmaceuticals, Inc. | Metabotrophic glutamate receptor 5 modulators and methods of use thereof |
WO2013049591A2 (en) | 2011-09-29 | 2013-04-04 | Verseon Corporation | Dual inhibitor compounds and methods of use thereof |
IN2014KN02410A (ru) | 2012-04-05 | 2015-05-01 | Vertex Pharma |
-
2014
- 2014-01-22 CN CN201480005179.8A patent/CN104936953B/zh active Active
- 2014-01-22 RU RU2015132370A patent/RU2644769C2/ru active
- 2014-01-22 AU AU2014208964A patent/AU2014208964B2/en active Active
- 2014-01-22 JP JP2015554244A patent/JP6307096B2/ja active Active
- 2014-01-22 WO PCT/GB2014/050163 patent/WO2014114928A1/en active Application Filing
- 2014-01-22 BR BR112015017331-4A patent/BR112015017331B1/pt active IP Right Grant
- 2014-01-22 AP AP2015008604A patent/AP2015008604A0/xx unknown
- 2014-01-22 KR KR1020157021103A patent/KR102202516B1/ko active IP Right Grant
- 2014-01-22 MX MX2015009465A patent/MX361136B/es active IP Right Grant
- 2014-01-22 CA CA2897279A patent/CA2897279C/en active Active
- 2014-01-22 PE PE2015001341A patent/PE20151979A1/es not_active Application Discontinuation
- 2014-01-22 SG SG11201505631PA patent/SG11201505631PA/en unknown
- 2014-01-22 MA MA38287A patent/MA38287B1/fr unknown
- 2014-01-22 AR ARP140100196A patent/AR094553A1/es unknown
- 2014-01-22 EP EP14701828.7A patent/EP2948447B1/en active Active
- 2014-01-22 US US14/160,650 patent/US9156831B2/en active Active
- 2014-01-22 ES ES14701828.7T patent/ES2608395T3/es active Active
- 2014-01-23 TW TW103102536A patent/TWI606047B/zh active
- 2014-01-23 UY UY0001035275A patent/UY35275A/es not_active Application Discontinuation
-
2015
- 2015-07-09 IL IL239890A patent/IL239890A0/en unknown
- 2015-07-10 CR CR20150367A patent/CR20150367A/es unknown
- 2015-07-16 DO DO2015000170A patent/DOP2015000170A/es unknown
- 2015-07-16 PH PH12015501584A patent/PH12015501584A1/en unknown
- 2015-07-21 CL CL2015002027A patent/CL2015002027A1/es unknown
- 2015-07-22 NI NI201500096A patent/NI201500096A/es unknown
- 2015-07-22 TN TN2015000313A patent/TN2015000313A1/en unknown
- 2015-08-31 US US14/840,209 patent/US9657008B2/en active Active
-
2016
- 2016-03-04 HK HK16102484.1A patent/HK1214592A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1222859A1 (zh) | 化合物 | |
HRP20180839T1 (hr) | Kemijske vrste | |
AP2015008713A0 (en) | Tetrahydropyrrolothiazine compounds | |
GB201304245D0 (en) | Chemical compounds | |
GB201309085D0 (en) | Compounds | |
GB201302927D0 (en) | Compounds | |
GB201310542D0 (en) | Compounds | |
HK1214592A1 (zh) | 化合物 | |
GB201309508D0 (en) | Compounds | |
AP3850A (en) | Azetidinyloxyphenylpyrrolidine compounds | |
EP3010923A4 (en) | PYRROLOCHINAZOLINVERBINDUNGEN | |
EP2948457A4 (en) | COMPOUNDS | |
GB201322733D0 (en) | Chemical compounds | |
GB201310460D0 (en) | Compounds | |
GB201306794D0 (en) | Compounds | |
GB201313885D0 (en) | Chemical Compounds | |
GB201306881D0 (en) | Chemical compounds | |
GB201310464D0 (en) | Compounds | |
GB201310115D0 (en) | Compounds | |
GB201310047D0 (en) | Compounds | |
GB201309728D0 (en) | Compounds | |
GB201309015D0 (en) | Compounds | |
GB201308975D0 (en) | Compounds | |
GB201308409D0 (en) | Compounds | |
GB201307938D0 (en) | Compounds |